リソソーム蓄積症治療の世界市場(現状・展望)2019年-2024年

【英語タイトル】Global Lysosomal Storage Disease Treatment Market Growth (Status and Outlook) 2019-2024

LP Informationが出版した調査資料(LPI-TB2716)・商品コード:LPI-TB2716
・発行会社(調査会社):LP Information
・発行日:2019年12月27日
・ページ数:115
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥417,240見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥625,860見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥834,480見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「リソソーム蓄積症治療の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、酵素補充療法、幹細胞移植、基質減少療法、その他など、用途別には、病院、診療所、幹移植センター、研究機関、その他などに区分してまとめた調査レポートです。リソソーム蓄積症治療のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・リソソーム蓄積症治療の世界市場概要(サマリー)
・リソソーム蓄積症治療の企業別販売量・売上
・リソソーム蓄積症治療の企業別市場シェア
・リソソーム蓄積症治療の世界市場規模:種類別(酵素補充療法、幹細胞移植、基質減少療法、その他)
・リソソーム蓄積症治療の世界市場規模:用途別(病院、診療所、幹移植センター、研究機関、その他)
・リソソーム蓄積症治療の米州市場規模(アメリカ、カナダ、メキシコなど)
・リソソーム蓄積症治療のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・リソソーム蓄積症治療の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・リソソーム蓄積症治療の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・リソソーム蓄積症治療市場の成長要因・課題・動向
・リソソーム蓄積症治療の世界市場予測
・リソソーム蓄積症治療の米州市場予測(アメリカ、カナダ、メキシコなど)
・リソソーム蓄積症治療のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・リソソーム蓄積症治療の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・リソソーム蓄積症治療の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・リソソーム蓄積症治療の世界市場予測:種類別(酵素補充療法、幹細胞移植、基質減少療法、その他)
・リソソーム蓄積症治療の世界市場予測:用途別(病院、診療所、幹移植センター、研究機関、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Lysosomal Storage Disease Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Lysosomal Storage Disease Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Lysosomal Storage Disease Treatment market by product type, application, key companies and key regions.

This study considers the Lysosomal Storage Disease Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Enzyme Replacement Therapy
Stem Cell Transplantation
Substrate Reduction Therapy
Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Stem Transplant Centers
Research Organizations
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Takeda
Pfizer
BioMarin
Merck
Sanofi
Actelion Pharmaceuticals
Eli Lilly

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Lysosomal Storage Disease Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Lysosomal Storage Disease Treatment market by identifying its various subsegments.
Focuses on the key global Lysosomal Storage Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Lysosomal Storage Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Lysosomal Storage Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

Global Lysosomal Storage Disease Treatment Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lysosomal Storage Disease Treatment Market Size 2014-2024
2.1.2 Lysosomal Storage Disease Treatment Market Size CAGR by Region
2.2 Lysosomal Storage Disease Treatment Segment by Type
2.2.1 Enzyme Replacement Therapy
2.2.2 Enzyme Replacement Therapy
2.2.3 Substrate Reduction Therapy
2.2.4 Others
2.3 Lysosomal Storage Disease Treatment Market Size by Type
2.3.1 Global Lysosomal Storage Disease Treatment Market Size Market Share by Type (2014-2019)
2.3.2 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type (2014-2019)
2.4 Lysosomal Storage Disease Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Stem Transplant Centers
2.4.4 Research Organizations
2.4.5 Others
2.5 Lysosomal Storage Disease Treatment Market Size by Application
2.5.1 Global Lysosomal Storage Disease Treatment Market Size Market Share by Application (2014-2019)
2.5.2 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Lysosomal Storage Disease Treatment by Players
3.1 Global Lysosomal Storage Disease Treatment Market Size Market Share by Players
3.1.1 Global Lysosomal Storage Disease Treatment Market Size by Players (2017-2019)
3.1.2 Global Lysosomal Storage Disease Treatment Market Size Market Share by Players (2017-2019)
3.2 Global Lysosomal Storage Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Lysosomal Storage Disease Treatment by Regions
4.1 Lysosomal Storage Disease Treatment Market Size by Regions
4.2 Americas Lysosomal Storage Disease Treatment Market Size Growth
4.3 APAC Lysosomal Storage Disease Treatment Market Size Growth
4.4 Europe Lysosomal Storage Disease Treatment Market Size Growth
4.5 Middle East & Africa Lysosomal Storage Disease Treatment Market Size Growth

5 Americas
5.1 Americas Lysosomal Storage Disease Treatment Market Size by Countries
5.2 Americas Lysosomal Storage Disease Treatment Market Size by Type
5.3 Americas Lysosomal Storage Disease Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Lysosomal Storage Disease Treatment Market Size by Countries
6.2 APAC Lysosomal Storage Disease Treatment Market Size by Type
6.3 APAC Lysosomal Storage Disease Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Lysosomal Storage Disease Treatment by Countries
7.2 Europe Lysosomal Storage Disease Treatment Market Size by Type
7.3 Europe Lysosomal Storage Disease Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Lysosomal Storage Disease Treatment by Countries
8.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type
8.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Lysosomal Storage Disease Treatment Market Forecast
10.1 Global Lysosomal Storage Disease Treatment Market Size Forecast (2019-2024)
10.2 Global Lysosomal Storage Disease Treatment Forecast by Regions
10.2.1 Global Lysosomal Storage Disease Treatment Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Lysosomal Storage Disease Treatment Forecast by Type
10.8 Global Lysosomal Storage Disease Treatment Forecast by Application

11 Key Players Analysis
11.1 Takeda
11.1.1 Company Details
11.1.2 Lysosomal Storage Disease Treatment Product Offered
11.1.3 Takeda Lysosomal Storage Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Takeda News
11.2 Pfizer
11.2.1 Company Details
11.2.2 Lysosomal Storage Disease Treatment Product Offered
11.2.3 Pfizer Lysosomal Storage Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Pfizer News
11.3 BioMarin
11.3.1 Company Details
11.3.2 Lysosomal Storage Disease Treatment Product Offered
11.3.3 BioMarin Lysosomal Storage Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 BioMarin News
11.4 Merck
11.4.1 Company Details
11.4.2 Lysosomal Storage Disease Treatment Product Offered
11.4.3 Merck Lysosomal Storage Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Merck News
11.5 Sanofi
11.5.1 Company Details
11.5.2 Lysosomal Storage Disease Treatment Product Offered
11.5.3 Sanofi Lysosomal Storage Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Sanofi News
11.6 Actelion Pharmaceuticals
11.6.1 Company Details
11.6.2 Lysosomal Storage Disease Treatment Product Offered
11.6.3 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Actelion Pharmaceuticals News
11.7 Eli Lilly
11.7.1 Company Details
11.7.2 Lysosomal Storage Disease Treatment Product Offered
11.7.3 Eli Lilly Lysosomal Storage Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Eli Lilly News

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Lysosomal Storage Disease Treatment
Figure Lysosomal Storage Disease Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Lysosomal Storage Disease Treatment Market Size Growth Rate 2014-2024 ($ Millions)
Table Lysosomal Storage Disease Treatment Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of Enzyme Replacement Therapy
Table Major Players of Stem Cell Transplantation
Table Major Players of Substrate Reduction Therapy
Table Major Players of Others
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Market Share by Type (2014-2019)
Figure Global Lysosomal Storage Disease Treatment Market Size Market Share by Type (2014-2019)
Figure Global Enzyme Replacement Therapy Market Size Growth Rate
Figure Global Stem Cell Transplantation Market Size Growth Rate
Figure Global Substrate Reduction Therapy Market Size Growth Rate
Figure Global Others Market Size Growth Rate
Figure Lysosomal Storage Disease Treatment Consume目录输出!D in Hospitals
Figure Global Lysosomal Storage Disease Treatment Market: Hospitals (2014-2019) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Lysosomal Storage Disease Treatment Consume目录输出!D in Clinics
Figure Global Lysosomal Storage Disease Treatment Market: Clinics (2014-2019) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Lysosomal Storage Disease Treatment Consume目录输出!D in Stem Transplant Centers
Figure Global Lysosomal Storage Disease Treatment Market: Stem Transplant Centers (2014-2019) ($ Millions)
Figure Global Stem Transplant Centers YoY Growth ($ Millions)
Figure Lysosomal Storage Disease Treatment Consume目录输出!D in Research Organizations
Figure Global Lysosomal Storage Disease Treatment Market: Research Organizations (2014-2019) ($ Millions)
Figure Global Research Organizations YoY Growth ($ Millions)
Figure Lysosomal Storage Disease Treatment Consume目录输出!D in Others
Figure Global Lysosomal Storage Disease Treatment Market: Others (2014-2019) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size by Application (2014-2019) ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Lysosomal Storage Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Lysosomal Storage Disease Treatment Market Size in Hospitals Growth Rate
Figure Global Lysosomal Storage Disease Treatment Market Size in Clinics Growth Rate
Figure Global Lysosomal Storage Disease Treatment Market Size in Stem Transplant Centers Growth Rate
Figure Global Lysosomal Storage Disease Treatment Market Size in Research Organizations Growth Rate
Figure Global Lysosomal Storage Disease Treatment Market Size in Others Growth Rate
Table Global Lysosomal Storage Disease Treatment Revenue by Players (2017-2019) ($ Millions)
Table Global Lysosomal Storage Disease Treatment Revenue Market Share by Players (2017-2019)
Figure Global Lysosomal Storage Disease Treatment Revenue Market Share by Players in 2018
Table Global Lysosomal Storage Disease Treatment Key Players Head office and Products Offered
Table Lysosomal Storage Disease Treatment Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Lysosomal Storage Disease Treatment Market Size by Regions 2014-2019 ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Market Share by Regions 2014-2019
Figure Global Lysosomal Storage Disease Treatment Market Size Market Share by Regions 2014-2019
Figure Americas Lysosomal Storage Disease Treatment Market Size 2014-2019 ($ Millions)
Figure APAC Lysosomal Storage Disease Treatment Market Size 2014-2019 ($ Millions)
Figure Europe Lysosomal Storage Disease Treatment Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Lysosomal Storage Disease Treatment Market Size 2014-2019 ($ Millions)
Table Americas Lysosomal Storage Disease Treatment Market Size by Countries (2014-2019) ($ Millions)
Table Americas Lysosomal Storage Disease Treatment Market Size Market Share by Countries (2014-2019)
Figure Americas Lysosomal Storage Disease Treatment Market Size Market Share by Countries in 2018
Table Americas Lysosomal Storage Disease Treatment Market Size by Type (2014-2019) ($ Millions)
Table Americas Lysosomal Storage Disease Treatment Market Size Market Share by Type (2014-2019)
Figure Americas Lysosomal Storage Disease Treatment Market Size Market Share by Type in 2018
Table Americas Lysosomal Storage Disease Treatment Market Size by Application (2014-2019) ($ Millions)
Table Americas Lysosomal Storage Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Americas Lysosomal Storage Disease Treatment Market Size Market Share by Application in 2018
Figure United States Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Canada Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Table APAC Lysosomal Storage Disease Treatment Market Size by Countries (2014-2019) ($ Millions)
Table APAC Lysosomal Storage Disease Treatment Market Size Market Share by Countries (2014-2019)
Figure APAC Lysosomal Storage Disease Treatment Market Size Market Share by Countries in 2018
Table APAC Lysosomal Storage Disease Treatment Market Size by Type (2014-2019) ($ Millions)
Table APAC Lysosomal Storage Disease Treatment Market Size Market Share by Type (2014-2019)
Figure APAC Lysosomal Storage Disease Treatment Market Size Market Share by Type in 2018
Table APAC Lysosomal Storage Disease Treatment Market Size by Application (2014-2019) ($ Millions)
Table APAC Lysosomal Storage Disease Treatment Market Size Market Share by Application (2014-2019)
Figure APAC Lysosomal Storage Disease Treatment Market Size Market Share by Application in 2018
Figure China Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Japan Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Korea Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure India Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Australia Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Table Europe Lysosomal Storage Disease Treatment Market Size by Countries (2014-2019) ($ Millions)
Table Europe Lysosomal Storage Disease Treatment Market Size Market Share by Countries (2014-2019)
Figure Europe Lysosomal Storage Disease Treatment Market Size Market Share by Countries in 2018
Table Europe Lysosomal Storage Disease Treatment Market Size by Type (2014-2019) ($ Millions)
Table Europe Lysosomal Storage Disease Treatment Market Size Market Share by Type (2014-2019)
Figure Europe Lysosomal Storage Disease Treatment Market Size Market Share by Type in 2018
Table Europe Lysosomal Storage Disease Treatment Market Size by Application (2014-2019) ($ Millions)
Table Europe Lysosomal Storage Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Europe Lysosomal Storage Disease Treatment Market Size Market Share by Application in 2018
Figure Germany Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure France Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure UK Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Italy Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Russia Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Spain Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Lysosomal Storage Disease Treatment Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Lysosomal Storage Disease Treatment Market Size Market Share by Countries in 2018
Table Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Lysosomal Storage Disease Treatment Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Lysosomal Storage Disease Treatment Market Size Market Share by Type in 2018
Table Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Lysosomal Storage Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Lysosomal Storage Disease Treatment Market Size Market Share by Application in 2018
Figure Egypt Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Israel Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Lysosomal Storage Disease Treatment Market Size Growth 2014-2019 ($ Millions)
Figure Global Lysosomal Storage Disease Treatment arket Size Forecast (2019-2024) ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Market Share Forecast by Regions
Figure Americas Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure APAC Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Europe Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure United States Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Canada Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Mexico Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Brazil Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure China Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Japan Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Korea Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure India Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Australia Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Germany Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure France Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure UK Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Italy Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Russia Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Spain Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Egypt Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure South Africa Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Israel Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure Turkey Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Figure GCC Countries Lysosomal Storage Disease Treatment Market Size 2019-2024 ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Market Share Forecast by Type (2019-2024)
Table Global Lysosomal Storage Disease Treatment Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Lysosomal Storage Disease Treatment Market Size Market Share Forecast by Application (2019-2024)
Table Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table Takeda Lysosomal Storage Disease Treatment Revenue and Gross Margin (2017-2019)
Figure Takeda Lysosomal Storage Disease Treatment Market Share (2017-2019)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Lysosomal Storage Disease Treatment Revenue and Gross Margin (2017-2019)
Figure Pfizer Lysosomal Storage Disease Treatment Market Share (2017-2019)
Table BioMarin Basic Information, Head Office, Major Market Areas and Its Competitors
Table BioMarin Lysosomal Storage Disease Treatment Revenue and Gross Margin (2017-2019)
Figure BioMarin Lysosomal Storage Disease Treatment Market Share (2017-2019)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Lysosomal Storage Disease Treatment Revenue and Gross Margin (2017-2019)
Figure Merck Lysosomal Storage Disease Treatment Market Share (2017-2019)
Table Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Lysosomal Storage Disease Treatment Revenue and Gross Margin (2017-2019)
Figure Sanofi Lysosomal Storage Disease Treatment Market Share (2017-2019)
Table Actelion Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Revenue and Gross Margin (2017-2019)
Figure Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Market Share (2017-2019)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Lysosomal Storage Disease Treatment Revenue and Gross Margin (2017-2019)
Figure Eli Lilly Lysosomal Storage Disease Treatment Market Share (2017-2019)


★調査レポート[リソソーム蓄積症治療の世界市場(現状・展望)2019年-2024年] (コード:LPI-TB2716)販売に関する免責事項を必ずご確認ください。
★調査レポート[リソソーム蓄積症治療の世界市場(現状・展望)2019年-2024年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆